RE:RE:RE:RE:RE:Not long until the AGMCancerSlayer wrote:
Jaro1977 wrote: If they take questions at the AGM, what would you be asking?
The most important wish for me is to have the ability to better gauge the durability of response. I would want to know the "absolute number" of patients who have reached the 270, 360 & 450 day assessment marks, & what number or percentage of those patients are CR. They could report these numbers for optimized patients only (+/- Ph 1b patients) & for the total patient population, including the underdosed first 12. That's a start.
Yes CS it`s not just a question for the AGM but price sensitive information seminal to any ability to properly value TLT that being in the Company`s possession and not of commercial sensitivity in relation to their intellectual property should absolutely have been released in a clear and unambiguous format already.